The rising prevalence of severe skin infections, particularly those linked to multidrug-resistant (MDR) bacteria, poses an increasing public health challenge. Although the systemic administration of broad-spectrum antibiotics such as colistin sulfate (CS) represents a last-resort treatment for these...
